Metabolism of stromal and immune cells in health and disease

Cancer cells have been at the centre of cell metabolism research, but the metabolism of stromal and immune cells has received less attention. Nonetheless, these cells influence the progression of malignant, inflammatory and metabolic disorders. Here we discuss the metabolic adaptations of stromal and immune cells in health and disease, and highlight how metabolism determines their differentiation and function.

[1]  R. Gillies,et al.  Why do cancers have high aerobic glycolysis? , 2004, Nature Reviews Cancer.

[2]  M. Junttila,et al.  Influence of tumour micro-environment heterogeneity on therapeutic response , 2013, Nature.

[3]  Daniel Rico,et al.  Substrate Fate in Activated Macrophages: A Comparison between Innate, Classic, and Alternative Activation , 2010, The Journal of Immunology.

[4]  R. Balling,et al.  Immune-responsive gene 1 protein links metabolism to immunity by catalyzing itaconic acid production , 2013, Proceedings of the National Academy of Sciences.

[5]  G. Schmitz,et al.  Induction of fatty acid synthesis is a key requirement for phagocytic differentiation of human monocytes , 2010, Proceedings of the National Academy of Sciences.

[6]  Christian M. Metallo,et al.  Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia , 2011, Nature.

[7]  O. Elemento,et al.  Metabolic Alterations in Lung Cancer–Associated Fibroblasts Correlated with Increased Glycolytic Metabolism of the Tumor , 2013, Molecular Cancer Research.

[8]  G. King,et al.  Vascular complications of diabetes: mechanisms of injury and protective factors. , 2013, Cell metabolism.

[9]  D. Green,et al.  HIF1α–dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells , 2011, The Journal of experimental medicine.

[10]  R. Brandes,et al.  Redox-mediated signal transduction by cardiovascular Nox NADPH oxidases. , 2014, Journal of molecular and cellular cardiology.

[11]  D. Green,et al.  Metabolic checkpoints in activated T cells , 2012, Nature Immunology.

[12]  R. Coletta,et al.  The fatty acid synthase inhibitor orlistat reduces experimental metastases and angiogenesis in B16-F10 melanomas , 2012, British Journal of Cancer.

[13]  W. Garrett,et al.  The Microbial Metabolites, Short-Chain Fatty Acids, Regulate Colonic Treg Cell Homeostasis , 2013, Science.

[14]  J. Spitzer,et al.  Glutamine and fatty acid oxidation are the main sources of energy for Kupffer and endothelial cells. , 1991, The American journal of physiology.

[15]  Chih-Hao Chang,et al.  Fueling Immunity: Insights into Metabolism and Lymphocyte Function , 2013, Science.

[16]  Matthew G. Vander Heiden,et al.  Metabolic targets for cancer therapy , 2013, Nature Reviews Drug Discovery.

[17]  S. Herzig,et al.  Immune cells and metabolic dysfunction , 2013, Seminars in Immunopathology.

[18]  J. Licht,et al.  Mitochondria are required for antigen-specific T cell activation through reactive oxygen species signaling. , 2013, Immunity.

[19]  Liang Zheng,et al.  Succinate is an inflammatory signal that induces IL-1β through HIF-1α , 2013, Nature.

[20]  Lingyun Wu,et al.  Aldolase B Knockdown Prevents High Glucose-Induced Methylglyoxal Overproduction and Cellular Dysfunction in Endothelial Cells , 2012, PloS one.

[21]  M. Mazzone,et al.  Tumor stroma: a complexity dictated by the hypoxic tumor microenvironment , 2014, Oncogene.

[22]  J. Rathmell,et al.  Glucose Uptake Is Limiting in T Cell Activation and Requires CD28-Mediated Akt-Dependent and Independent Pathways1 , 2008, The Journal of Immunology.

[23]  H. Schreiber,et al.  Innate and adaptive immune cells in the tumor microenvironment , 2013, Nature Immunology.

[24]  J. Loscalzo,et al.  Aldosterone impairs vascular reactivity by decreasing glucose-6-phosphate dehydrogenase activity , 2007, Nature Medicine.

[25]  M. V. Vander Heiden,et al.  Aerobic glycolysis: meeting the metabolic requirements of cell proliferation. , 2011, Annual review of cell and developmental biology.

[26]  Jesse M. Platt,et al.  Hypoxia promotes isocitrate dehydrogenase-dependent carboxylation of α-ketoglutarate to citrate to support cell growth and viability , 2011, Proceedings of the National Academy of Sciences.

[27]  W. Jarmuszkiewicz,et al.  The influence of high glucose on the aerobic metabolism of endothelial EA.hy926 cells , 2012, Pflügers Archiv - European Journal of Physiology.

[28]  G. V. D. van der Windt,et al.  Mitochondrial respiratory capacity is a critical regulator of CD8+ T cell memory development. , 2012, Immunity.

[29]  Tom T. Chen,et al.  ApoB-containing lipoproteins regulate angiogenesis by modulating expression of VEGF receptor 1 , 2012, Nature Medicine.

[30]  Chao Liu,et al.  Control of Angiogenesis by AIBP-mediated Cholesterol Efflux , 2013, Nature.

[31]  Aristotelis Tsirigos,et al.  Understanding the "lethal" drivers of tumor-stroma co-evolution , 2010, Cancer biology & therapy.

[32]  M. Kurtoğlu,et al.  Antiangiogenic Activity of 2-Deoxy-D-Glucose , 2010, PloS one.

[33]  Bai Luo,et al.  Protein Modification by O-Linked GlcNAc Reduces Angiogenesis by Inhibiting Akt Activity in Endothelial Cells , 2008, Arteriosclerosis, thrombosis, and vascular biology.

[34]  A. Sica,et al.  Macrophage plasticity and polarization in tissue repair and remodelling , 2013, The Journal of pathology.

[35]  Divya Vats,et al.  Oxidative metabolism and PGC-1beta attenuate macrophage-mediated inflammation. , 2006, Cell metabolism.

[36]  W. Wong,et al.  Hypoxia-inducible factors and the response to hypoxic stress. , 2010, Molecular cell.

[37]  P. Grudnik,et al.  T cell activation is driven by an ADP-dependent glucokinase linking enhanced glycolysis with mitochondrial reactive oxygen species generation. , 2012, Cell reports.

[38]  F. Sotgia,et al.  Warburg meets autophagy: cancer-associated fibroblasts accelerate tumor growth and metastasis via oxidative stress, mitophagy, and aerobic glycolysis. , 2012, Antioxidants & redox signaling.

[39]  S. Ziyad,et al.  A Ligand-Independent VEGFR2 Signaling Pathway Limits Angiogenic Responses in Diabetes , 2014, Science Signaling.

[40]  T. Noll,et al.  Energetic response of coronary endothelial cells to hypoxia. , 1990, The American journal of physiology.

[41]  W. Zwerschke,et al.  Premature senescence of human endothelial cells induced by inhibition of glutaminase , 2008, Biogerontology.

[42]  O Feron,et al.  Endothelial cell metabolism and tumour angiogenesis: glucose and glutamine as essential fuels and lactate as the driving force , 2013, Journal of internal medicine.

[43]  G. Wu,et al.  Glutamine metabolism in endothelial cells: ornithine synthesis from glutamine via pyrroline-5-carboxylate synthase. , 2000, Comparative biochemistry and physiology. Part A, Molecular & integrative physiology.

[44]  L. O’Neill.  A critical role for citrate metabolism in LPS signalling. , 2011, The Biochemical journal.

[45]  J. Rathmell,et al.  Cutting Edge: Distinct Glycolytic and Lipid Oxidative Metabolic Programs Are Essential for Effector and Regulatory CD4+ T Cell Subsets , 2011, The Journal of Immunology.

[46]  D. Puro,et al.  Extracellular lactate as a dynamic vasoactive signal in the rat retinal microvasculature. , 2006, American journal of physiology. Heart and circulatory physiology.

[47]  R. Bucala,et al.  Small molecule inhibition of 6-phosphofructo-2-kinase suppresses t cell activation , 2012, Journal of Translational Medicine.

[48]  Holger Gerhardt,et al.  Basic and Therapeutic Aspects of Angiogenesis , 2011, Cell.

[49]  R. Deberardinis,et al.  Cellular Metabolism and Disease: What Do Metabolic Outliers Teach Us? , 2012, Cell.

[50]  E. Gottlieb,et al.  The music of lipids: How lipid composition orchestrates cellular behaviour , 2012, Acta oncologica.

[51]  M. Tomita,et al.  Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells , 2013, Nature.

[52]  P. Carmeliet,et al.  Role of PFKFB3-Driven Glycolysis in Vessel Sprouting , 2013, Cell.

[53]  M. Hill.  Emerging Role for Antioxidant Therapy in Protection Against Diabetic Cardiac Complications: Experimental and Clinical Evidence for Utilization of Classic and New Antioxidants , 2008, Current cardiology reviews.

[54]  J. Rathmell,et al.  Metabolic regulation of T lymphocytes. , 2013, Annual review of immunology.

[55]  P. Kador,et al.  Aldose reductase / polyol inhibitors for diabetic retinopathy. , 2011, Current pharmaceutical biotechnology.

[56]  Charles D Mills,et al.  M1 and M2 Macrophages: Oracles of Health and Disease. , 2012, Critical reviews in immunology.

[57]  M. Surette,et al.  Fatty acid remodeling in cellular glycerophospholipids following the activation of human T cells[S] , 2013, Journal of Lipid Research.

[58]  J. Schaper,et al.  Ultrastructural quantitation of mitochondria and myofilaments in cardiac muscle from 10 different animal species including man. , 1992, Journal of molecular and cellular cardiology.

[59]  W. Banks,et al.  Pharmacological Inhibition of Mitochondrial Carbonic Anhydrases Protects Mouse Cerebral Pericytes from High Glucose-Induced Oxidative Stress and Apoptosis , 2013, The Journal of Pharmacology and Experimental Therapeutics.

[60]  S. Moncada,et al.  Mitochondria as signaling organelles in the vascular endothelium. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[61]  J. Verrax,et al.  Lactate Activates HIF-1 in Oxidative but Not in Warburg-Phenotype Human Tumor Cells , 2012, PloS one.

[62]  J. Schneider,et al.  De Novo Lipogenesis Maintains Vascular Homeostasis through Endothelial Nitric-oxide Synthase (eNOS) Palmitoylation*♦ , 2010, The Journal of Biological Chemistry.

[63]  P. Carmeliet,et al.  Molecular mechanisms and clinical applications of angiogenesis , 2011, Nature.

[64]  D. Hardie,et al.  Metabolism of inflammation limited by AMPK and pseudo-starvation , 2013, Nature.

[65]  U. Förstermann,et al.  Nitric oxide synthases: regulation and function. , 2012, European heart journal.

[66]  Mark S. Sundrud,et al.  Halofuginone Inhibits TH17 Cell Differentiation by Activating the Amino Acid Starvation Response , 2009, Science.

[67]  R. Kawamori,et al.  Long-term clinical effects of epalrestat, an aldose reductase inhibitor, on progression of diabetic neuropathy and other microvascular complications: multivariate epidemiological analysis based on patient background factors and severity of diabetic neuropathy , 2012, Diabetic medicine : a journal of the British Diabetic Association.

[68]  G. Glick,et al.  Effector T cells require fatty acid metabolism during murine graft-versus-host disease. , 2013, Blood.

[69]  V. Nizet,et al.  Interdependence of hypoxic and innate immune responses , 2009, Nature Reviews Immunology.

[70]  T. Gajewski,et al.  Glucose deprivation inhibits multiple key gene expression events and effector functions in CD8+ T cells , 2008, European journal of immunology.

[71]  K. Martin,et al.  Aldose Reductase, Oxidative Stress, and Diabetic Mellitus , 2012, Front. Pharmacol..

[72]  L. Rossetti,et al.  Inhibition of GAPDH activity by poly(ADP-ribose) polymerase activates three major pathways of hyperglycemic damage in endothelial cells. , 2003, The Journal of clinical investigation.

[73]  B. Kuze,et al.  Dichloroacetate improves immune dysfunction caused by tumor‐secreted lactic acid and increases antitumor immunoreactivity , 2013, International journal of cancer.

[74]  Z. Bagi,et al.  Activation of hexosamine pathway impairs nitric oxide (NO)-dependent arteriolar dilations by increased protein O-GlcNAcylation. , 2012, Vascular pharmacology.

[75]  K. Frauwirth,et al.  Glutamine Uptake and Metabolism Are Coordinately Regulated by ERK/MAPK during T Lymphocyte Activation , 2010, The Journal of Immunology.

[76]  G. Glick,et al.  Distinct metabolic programs in activated T cells: opportunities for selective immunomodulation , 2012, Immunological reviews.

[77]  D. Sisci,et al.  G Protein-coupled Estrogen Receptor Mediates the Up-regulation of Fatty Acid Synthase Induced by 17β-Estradiol in Cancer Cells and Cancer-associated Fibroblasts* , 2012, The Journal of Biological Chemistry.

[78]  I. Chowers,et al.  Impaired cholesterol efflux in senescent macrophages promotes age-related macular degeneration. , 2013, Cell metabolism.

[79]  D. Green,et al.  The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation. , 2011, Immunity.

[80]  B. Faubert,et al.  Posttranscriptional Control of T Cell Effector Function by Aerobic Glycolysis , 2013, Cell.

[81]  R. Ramasamy,et al.  Unlocking the biology of RAGE in diabetic microvascular complications , 2014, Trends in Endocrinology & Metabolism.

[82]  Gregory Stephanopoulos,et al.  Amplification of phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesis , 2012, BMC Proceedings.

[83]  P. Carmeliet,et al.  Partial and transient reduction of glycolysis by PFKFB3 blockade reduces pathological angiogenesis. , 2014, Cell metabolism.

[84]  J. Becker,et al.  Immune-suppressive properties of the tumor microenvironment , 2013, Cancer Immunology, Immunotherapy.

[85]  Alberto Mantovani,et al.  Orchestration of metabolism by macrophages. , 2012, Cell metabolism.

[86]  Takla Griss,et al.  The Liver Kinase B1 Is a Central Regulator of T Cell Development, Activation, and Metabolism , 2011, The Journal of Immunology.

[87]  G. Mills,et al.  Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth , 2011, Nature Medicine.

[88]  A. Harris,et al.  How cancer metabolism is tuned for proliferation and vulnerable to disruption , 2012, Nature.

[89]  A. Kazlauskas,et al.  Lactate Engages Receptor Tyrosine Kinases Axl, Tie2, and Vascular Endothelial Growth Factor Receptor 2 to Activate Phosphoinositide 3-Kinase/Akt and Promote Angiogenesis* , 2013, The Journal of Biological Chemistry.

[90]  Kathryn E. Crosier,et al.  Immunoresponsive gene 1 augments bactericidal activity of macrophage-lineage cells by regulating β-oxidation-dependent mitochondrial ROS production. , 2013, Cell metabolism.

[91]  J. Kipnis,et al.  Extracellular Redox Modulation by Regulatory T Cells† , 2009, Nature chemical biology.

[92]  G. McMahon,et al.  Intensive glycemic control in the ACCORD and ADVANCE trials. , 2008, The New England journal of medicine.

[93]  J. Loscalzo,et al.  Glucose-6-Phosphate Dehydrogenase Overexpression Decreases Endothelial Cell Oxidant Stress and Increases Bioavailable Nitric Oxide , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[94]  Elizabeth L. Johnson,et al.  Quiescent Fibroblasts Exhibit High Metabolic Activity , 2010, PLoS biology.

[95]  S. Jameson,et al.  Diversity in T cell memory: an embarrassment of riches. , 2009, Immunity.

[96]  Charles R. Evans,et al.  The Sedoheptulose Kinase CARKL Directs Macrophage Polarization through Control of Glucose Metabolism , 2012, Cell metabolism.

[97]  HIF1a–dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells , 2011 .

[98]  M. Milanick.  Na-Ca exchange: evidence against a ping-pong mechanism and against a Ca pool in ferret red blood cells. , 1991, The American journal of physiology.

[99]  A. Rudensky,et al.  Metabolites produced by commensal bacteria promote peripheral regulatory T cell generation , 2013, Nature.

[100]  Linda V. Sinclair,et al.  Control of amino-acid transport by antigen receptors coordinates the metabolic reprogramming essential for T cell differentiation , 2013, Nature Immunology.

[101]  R. Fernandes,et al.  Methylglyoxal promotes oxidative stress and endothelial dysfunction. , 2012, Pharmacological research.

[102]  N. Ruderman,et al.  Acute Regulation of Fatty Acid Oxidation and AMP-Activated Protein Kinase in Human Umbilical Vein Endothelial Cells , 2001, Circulation research.

[103]  Pier Paolo Pandolfi,et al.  Cancer metabolism: fatty acid oxidation in the limelight , 2013, Nature Reviews Cancer.

[104]  John O Trent,et al.  Small-molecule inhibition of 6-phosphofructo-2-kinase activity suppresses glycolytic flux and tumor growth , 2008, Molecular Cancer Therapeutics.

[105]  Young‐Hee Kang,et al.  Pyruvate protection against endothelial cytotoxicity induced by blockade of glucose uptake. , 2004, Journal of biochemistry and molecular biology.

[106]  H. Zeh,et al.  Arginine and immunity. , 2007, The Journal of nutrition.

[107]  P. Muranski,et al.  Inhibiting glycolytic metabolism enhances CD8+ T cell memory and antitumor function. , 2013, The Journal of clinical investigation.

[108]  Pierre Sonveaux,et al.  Lactate influx through the endothelial cell monocarboxylate transporter MCT1 supports an NF-κB/IL-8 pathway that drives tumor angiogenesis. , 2011, Cancer research.